Medication info
Feminine 625 mg Tablets [Amoxicillin Trihydrate · Clavulanate Potassium (4:1)]

Feminine 625 mg Tablets [Amoxicillin Trihydrate · Clavulanate Potassium (4:1)]

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›500mg / 1 tabletDilute Potassium Clavulanate›212.73mg / 1 tablet
Manufacturer / importer
Illhwa Co., Ltd.
Appearance
White or nearly white oval film-coated tablet
Packaging
40 tablets/box [(4 tablets/PTP X 10)]
Approval status
Active

MFDS item code 201309809 · Approved 2013.10.18 · Insurance code 640902650

Summary

Main use
Treatment of respiratory, genitourinary, skin, bone, and dental infections
Who takes it
Adults · Children
Adult dose
The dose of this drug should be determined according to the patient's age, body weight, renal function, and the severity of the infection. Administer at the beginning of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the beginning of a meal. Adults: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate orally 3 times daily every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. Adults: Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is necessary for patients with a creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min: Administer 250 ~ 500 mg of amoxicillin orally per dose every 12 hours. 10 mL/min or less: Administer 250 mg of amoxicillin every 24 hours; do not exceed this dose. Hemodialysis: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, administer an additional dose during dialysis, and repeat the dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanate decrease.)
Child dose
Children aged 12 years or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate orally 3 times daily every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. Children with renal impairment: Reduce the dose in the same manner.

Ingredients

Manufacturer
Illhwa Co., Ltd.

Efficacy & effects

Treatment of respiratory, genitourinary, skin, bone, and dental infections

  • Acute and chronic bronchitis
  • lobar pneumonia
  • bronchopneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic infections
View approved original text

This medication is effective against various bacterial infections. It is used for respiratory infections such as acute and chronic bronchitis, lobar and bronchial pneumonia, empyema, lung abscess, tonsillitis, sinusitis, and otitis media. It is also effective for urogenital infections such as cystitis, urethritis, and pyelonephritis. It is applied in the treatment of various infections including pelvic inflammatory disease, gonorrhea, furuncles and abscesses, soft tissue infections, wound infections, osteomyelitis, and dental infections. This medication exhibits antibacterial effects against various strains such as Staphylococcus aureus, Escherichia coli, and Neisseria gonorrhoeae, improving infection symptoms. Therefore, it is safely and effectively used for the treatment of several bacterial infections.

How to take

Adult dose

The dose of this drug should be determined according to the patient's age, body weight, renal function, and the severity of the infection. Administer at the beginning of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the beginning of a meal. Adults: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate orally 3 times daily every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. Adults: Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is necessary for patients with a creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min: Administer 250 ~ 500 mg of amoxicillin orally per dose every 12 hours. 10 mL/min or less: Administer 250 mg of amoxicillin every 24 hours; do not exceed this dose. Hemodialysis: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, administer an additional dose during dialysis, and repeat the dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanate decrease.)

Child dose

Children aged 12 years or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate orally 3 times daily every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. Children with renal impairment: Reduce the dose in the same manner.

Precautions

This medication is a beta-lactam antibiotic belonging to the penicillin group, and should not be administered to patients with a history of allergic reactions or specific viral infections. Patients with impaired liver or kidney function should use it with caution due to the risk of side effects. If unusual symptoms such as diarrhea, rash, or difficulty breathing occur while taking this medication, you should consult a physician immediately, and in severe cases, discontinue use. With prolonged use, periodic checks for the possibility of resistant bacteria and liver or kidney function decline should be performed. Women who are pregnant or breastfeeding should have the use of this medication carefully considered, and it is especially recommended to avoid use in early pregnancy. Additionally, this medication may interact with other drugs, so it is essential to inform healthcare professionals of any concurrent medications. In case of overdose, symptoms like vomiting, diarrhea, rash, and convulsions may occur, requiring immediate medical attention. When storing, keep it in a dry and cool place, and out of the reach of children.

Side effects

Diarrhea, pseudomembranous colitis, dyspepsia, stomatitis, gastritis, glossitis, black hairy tongue, nausea, vomiting, appetite loss, abdominal pain, abdominal bloating, constipation, colonic pain, hyperacidity, loose stools, xerostomia, acute pancreatitis, candidiasis, antibiotic-induced colitis, severe colitis with bloody stools, elevated AST, elevated ALT, elevated ALP, elevated LDH, elevated serum bilirubin, hepatitis, cholestatic jaundice, pruritus, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, bullous exfoliative dermatitis, acute generalized exanthematous pustulosis, drug reactions with eosinophilia and systemic symptoms, angioedema, anaphylaxis, serum sickness syndrome, hypersensitivity vasculitis, respiratory distress with bronchospasm, laryngeal edema, anaphylactic shock, reversible leukopenia, reversible thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphocytopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, mucosal candidiasis, vaginal itching, vaginal burning, increased discharge, agitation, anxiety, behavioral changes, confusion, drowsiness, insomnia, reversible hyperactivity, dizziness, headache, seizures, antiparkinsonian activity, fever, altered consciousness, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, crystalluria, vitamin K deficiency symptoms, vitamin B complex deficiency symptoms, linear IgA disease, dysgeusia, malaise, dermatitis, oral edema, gastric pain, fluid and electrolyte imbalance, rash, hyperactivity, drowsiness, renal failure, interstitial cerebral seizures, hypersensitivity shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent moisture, at a cool temperature between 1 degree and 25 degrees Celsius. Proper storage maintains the medication's efficacy for a longer period.

Appearance and packaging

Appearance

White or nearly white oval film-coated tablet

Package unit

40 tablets/box [(4 tablets/PTP X 10)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.